Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trial.

Nieminen H, Rinta-Kokko H, Jokinen J, Puumalainen T, Moreira M, Borys D, Schuerman L, Palmu AA.

Vaccine. 2019 Jun 19;37(28):3715-3721. doi: 10.1016/j.vaccine.2019.05.033. Epub 2019 May 20.

2.

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.

Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A, Mereckiene J, Knol M, Winje BA, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Slotved HC, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Latasa P, Castilla J, Smith A, Henriques-Normark B, Whittaker R, Pastore Celentano L, Savulescu C; SpIDnet/I-MOVE+ Pneumo Group.

Thorax. 2019 May;74(5):473-482. doi: 10.1136/thoraxjnl-2018-211767. Epub 2018 Oct 24.

3.

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.

Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA.

Vaccine. 2018 Sep 18;36(39):5891-5901. doi: 10.1016/j.vaccine.2018.08.020. Epub 2018 Aug 23.

4.

Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children.

Artama M, Rinta-Kokko H, Nohynek H, Jokinen J, Palmu AA.

Curr Drug Saf. 2018;13(2):107-112. doi: 10.2174/1574886313666180406164151.

5.

A pneumococcal conjugate vaccination programme reduced clinically suspected invasive disease in unvaccinated children.

Palmu AA, Rinta-Kokko H, Nuorti JP, Nohynek H, Jokinen J.

Acta Paediatr. 2018 Mar 25. doi: 10.1111/apa.14335. [Epub ahead of print]

PMID:
29577411
6.

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.

Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J.

Vaccine. 2018 Apr 5;36(15):1934-1940. doi: 10.1016/j.vaccine.2018.03.001. Epub 2018 Mar 8.

PMID:
29526371
7.

Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Vaccine. 2018 Mar 27;36(14):1816-1822. doi: 10.1016/j.vaccine.2018.02.088.

8.

Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Jokinen J.

Pediatr Infect Dis J. 2018 Jan;37(1):97-102. doi: 10.1097/INF.0000000000001810.

PMID:
29088026
9.

Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland.

Okasha O, Rinta-Kokko H, Palmu AA, Ruokokoski E, Jokinen J, Nuorti JP.

Thorax. 2018 Mar;73(3):262-269. doi: 10.1136/thoraxjnl-2017-210440. Epub 2017 Oct 7.

PMID:
28988217
10.

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J.

PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.

11.

Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Traskine M, Moreira M, Borys D, Schuerman L, Kilpi TM.

Pediatr Infect Dis J. 2015 Nov;34(11):1230-5. doi: 10.1097/INF.0000000000000857.

PMID:
26284652
12.

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J.

Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15.

13.

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP.

PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.

14.

Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Borys D, Lommel P, Traskine M, Moreira M, Schuerman L, Kilpi TM.

Lancet Infect Dis. 2014 Mar;14(3):205-12. doi: 10.1016/S1473-3099(13)70338-4. Epub 2013 Nov 26.

PMID:
24287186
15.

Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H; Pneumococcal Carriage Group (PneumoCarr).

Vaccine. 2013 Dec 17;32(1):153-8. doi: 10.1016/j.vaccine.2013.08.061. Epub 2013 Sep 7. Review.

PMID:
24016803
16.

Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H.

Vaccine. 2013 Dec 17;32(1):159-64. doi: 10.1016/j.vaccine.2013.06.105. Epub 2013 Jul 18. Review.

17.

Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study.

Auranen K, Rinta-Kokko H, Halloran ME.

Biometrics. 2013 Mar;69(1):235-44. doi: 10.1111/j.1541-0420.2012.01826.x. Epub 2013 Feb 4.

18.

Estimation of vaccine efficacy against acquisition of pneumococcal carriage.

Rinta-Kokko H, Dagan R, Givon-Lavi N, Auranen K.

Vaccine. 2009 Jun 12;27(29):3831-7. doi: 10.1016/j.vaccine.2009.04.009. Epub 2009 Apr 23. Review.

PMID:
19490983

Supplemental Content

Loading ...
Support Center